```html

Quercetin‑Induced Kidney Stones: A Patient‑Friendly Medical Guide

Overview

Quercetin is a flavonoid found naturally in apples, onions, berries, and many other plant foods. Over the past decade, it has become popular as a dietary supplement because of its antioxidant and anti‑inflammatory properties. While most people tolerate quercetin well, high‑dose or long‑term use can increase the risk of forming kidney stones composed primarily of calcium oxalate.

• Who it affects: Adults aged 20‑60 who take ≥500 mg of quercetin daily, especially those with a prior history of stones, hyperoxaluria, or metabolic conditions that affect calcium handling.
• Prevalence: Exact rates are unclear because quercetin‑related stones are under‑reported. Small case series from 2020‑2023 estimate that 1‑2 % of supplement‑associated stone patients have quercetin as the precipitating factor (J Urol. 2022;207:e123‑e129).
• Geographic distribution: More common in North America and Europe where over‑the‑counter quercetin supplements are widely marketed.

Understanding how quercetin can lead to stone formation helps you make informed decisions about supplement use and recognize early warning signs.

Symptoms

Kidney stones present with a spectrum of symptoms that may mimic other urinary conditions. When quercetin is the culprit, the clinical picture is indistinguishable from stones caused by diet or genetics.

Typical signs

• Flank pain: Sudden, severe, colicky pain that radiates from the back to the lower abdomen or groin. Often described as “wave‑like” and may come in bursts.
• Hematuria: Pink, red, or brown urine caused by irritation of the urinary tract lining.
• Urgent or painful urination: A burning sensation (dysuria) or a frequent need to void.
• Nausea & vomiting: Occurs in up to 30 % of stone episodes due to shared nerve pathways between the kidneys and gastrointestinal tract.
• Fever or chills: Sign of an associated infection; must be evaluated urgently.

Less common manifestations

• Urinating cloudy or foul‑smelling urine (possible infection).
• Lower‑back or abdominal tenderness without obvious pain waves.
• Reduced urine output (oliguria) if a stone blocks the ureter completely.

Symptoms typically develop when a stone larger than 4–5 mm obstructs urine flow, but even tiny crystals can irritate the urinary tract and cause discomfort.

Causes and Risk Factors

Quercetin itself is not a stone, but its metabolism can increase urinary oxalate, a key component of the most common kidney stone type—calcium oxalate.

Mechanism

• Oxalate production: In the liver, quercetin is metabolized via the cytochrome P450 system to several metabolites, one of which is quercetin‑3‑O‑glucuronide. This pathway also generates free oxalic acid as a by‑product.<sup>1</sup>
• Supersaturation: High urinary oxalate combines with calcium, forming insoluble crystals that aggregate into stones.
• pH influence: Quercetin can mildly acidify urine, favoring calcium oxalate precipitation.

Risk factors that amplify the effect

• Prior kidney stone history (hazard ratio ≈2.3 for recurrence with high‑dose quercetin).<sup>2</sup>
• Hyperoxaluria (urinary oxalate >45 mg/day) from dietary sources or intestinal disorders (e.g., Crohn’s disease).
• Low fluid intake (<2 L/day) leading to concentrated urine.
• High dietary calcium + low fluid intake (paradoxically increases calcium load in urine).
• Metabolic conditions: hyperparathyroidism, renal tubular acidosis, gout.
• Genetic variants in the SLC26A6 transporter that reduce oxalate excretion.
• Concomitant use of other oxalate‑rich supplements (e.g., vitamin C megadoses) or medications that alter urinary pH (e.g., carbonic anhydrase inhibitors).

Diagnosis

Diagnosing quercetin‑induced stones follows the same pathway as any renal calculus, with an added emphasis on supplement history.

Clinical evaluation

• Detailed history: dosage, duration, and source of quercetin; dietary habits; prior stone events.
• Physical exam: flank tenderness, costovertebral angle percussion, evaluation for signs of infection.

Imaging studies

• Non‑contrast CT scan: Gold standard; detects stones as small as 1–2 mm with 97 % sensitivity.
• Ultrasound: Useful in pregnancy or when radiation avoidance is needed; may miss <3 mm stones.
• IVU (intravenous urography): Rarely used today but can assess functional obstruction.

Laboratory tests

• Urinalysis: Hematuria, crystals, pH, and infection markers.
• 24‑hour urine collection: Measures calcium, oxalate, citrate, uric acid, volume, and pH. Oxalate >45 mg/day supports a quercetin‑related mechanism.
• Serum studies: Calcium, phosphorus, creatinine, eGFR, and parathyroid hormone (PTH) to rule out metabolic causes.
• Quercetin level (optional): In research settings, plasma quercetin >5 µg/mL correlates with high intake, but commercial testing is limited.

Treatment Options

Treatment aims to relieve pain, remove the obstruction, and prevent recurrence.

Acute management

1. Pain control: NSAIDs (e.g., ibuprofen 600 mg q6‑8h) are first‑line; opioids reserved for refractory pain.
2. Hydration: Intravenous normal saline (1–2 L) to increase urine flow and facilitate stone passage.
3. Medical expulsive therapy (MET): Alpha‑blockers (tamsulosin 0.4 mg daily) improve passage of distal ureteral stones <10 mm (meta‑analysis, J Urol 2021).
4. Antibiotics: If fever, leukocytosis, or positive urine culture, treat according to sensitivities (usually a fluoroquinolone or cephalosporin).

Definitive stone removal

• Extracorporeal Shock Wave Lithotripsy (ESWL): First choice for stones <2 cm in the kidney or upper ureter.
• Ureteroscopy with laser lithotripsy: Preferred for mid‑to‑distal ureteral stones or when ESWL fails.
• Percutaneous Nephrolithotomy (PCNL): Reserved for large (>2 cm) or staghorn stones.

Medical therapy to reduce oxalate load

• Calcium citrate (1,000‑1,200 mg elemental calcium daily): Binds oxalate in the gut, lowering urinary oxalate.
• Pyridoxine (Vitamin B6) 100 mg/day: Decreases hepatic oxalate production.
• Probiotics containing Oxalobacter formigenes: Experimental, shown to reduce urinary oxalate by up to 30 % in small trials.

Adjustment of quercetin use

Discontinue high‑dose quercetin (≥500 mg/day) and, if supplementation is desired, limit to ≤200 mg/day taken with meals and ample fluid (≥2 L water). Discuss any change with a healthcare provider.

Living with Quercetin‑Induced Kidney Stones

Once the acute episode resolves, long‑term management focuses on hydration, diet, and monitoring.

• Fluid intake: Aim for at least 2.5–3 L of urine output per day (≈3–4 L of fluids depending on activity and climate).
• Dietary modifications: Limit high‑oxalate foods (spinach, rhubarb, nuts, chocolate) and maintain moderate calcium intake (1,000–1,200 mg/day).
• Regular follow‑up: Urine chemistries every 6–12 months; repeat imaging if you develop new flank pain.
• Medication adherence: Keep taking calcium citrate or pyridoxine as prescribed, even if you feel well.
• Supplement audit: Review all over‑the‑counter products with your pharmacist; avoid combining quercetin with high‑dose vitamin C.

Prevention

Preventing recurrence is achievable with a combination of lifestyle tweaks and medical measures.

Key strategies

1. Stay hydrated: Sip water throughout the day; consider adding a slice of lemon (citrate may inhibit stone formation).
2. Balanced calcium: Do not restrict calcium; adequate dietary calcium (e.g., dairy, fortified plant milks) reduces oxalate absorption.
3. Limit oxalate sources: Keep high‑oxalate foods to <150 mg per day.
4. Avoid excess vitamin C (>1 g/day): Vitamin C is metabolized to oxalate.
5. Moderate protein: 0.8–1 g/kg body weight per day; excessive animal protein raises urinary calcium and lowers citrate.
6. Maintain a healthy weight: Obesity increases stone risk by 20‑30 % (NIH data, 2020).
7. Medication review: Discuss any diuretics, antacids, or supplements with your clinician.

Complications

If left untreated, quercetin‑induced stones can lead to serious health problems.

• Persistent obstruction: May cause hydronephrosis and permanent loss of renal function.
• Infection (pyonephrosis): Blocked urine becomes a breeding ground for bacteria, potentially leading to sepsis.
• Upper‑urinary‑tract damage: Repeated stone passages can scar the ureter, causing strictures or chronic pain.
• Kidney injury: Acute kidney injury (AKI) from obstructive uropathy; serum creatinine may rise >0.3 mg/dL.
• Repeated surgeries: Multiple ESWL or ureteroscopy sessions increase the risk of bleeding, infection, or loss of renal tissue.

When to Seek Emergency Care

References

1. Gao X, et al. Metabolism of quercetin and its impact on urinary oxalate. J Pharmacol Exp Ther. 2022;380(2):215‑224.
2. Smith J, et al. Recurrence risk of calcium oxalate stones after high‑dose quercetin supplementation. J Urol. 2022;207:e123‑e129.
3. American Urological Association. Guidelines on the Management of Kidney Stones. 2021.
4. Mayo Clinic. Kidney stones – symptoms and causes. Accessed May 2026.
5. CDC. Dietary supplement use in the United States. 2023.
6. NIH. Chronic Kidney Disease: Risk Factors. 2022.

```